Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of neurological disorders, increasing prevalence of brain tumors, and rising funding for neurology research.
The neurophotonics market is segmented as below:
By Application
- Research
- Therapeutics
By Type
- Microscopy
- Spectroscopy
- Multimodal
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the neurophotonics market covers the following areas:
- Neurophotonics market sizing
- Neurophotonics market forecast
- Neurophotonics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global neurophotonics market: Artinis Medical Systems, Bruker Corp., Cairn Research Ltd., Carl Zeiss AG, Danaher Corp., Femtonics Ltd., Hitachi Ltd., HORIBA Ltd., Intelligent Imaging Innovations Inc., ISS Inc., Nanoscope Technologies LLC, NIRx Medical Technologies LLC, PerkinElmer Inc, Thermo Fisher Scientific Inc., and Vielight Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is future opportunities in neurophotonics.'
According to the report, one of the major drivers for this market is the increasing prevalence of neurological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Artinis Medical Systems
- Bruker Corp.
- Cairn Research Ltd.
- Carl Zeiss AG
- Danaher Corp.
- Femtonics Ltd.
- Hitachi Ltd.
- HORIBA Ltd.
- Intelligent Imaging Innovations Inc.
- ISS Inc.
- Nanoscope Technologies LLC
- NIRx Medical Technologies LLC
- PerkinElmer Inc
- Thermo Fisher Scientific Inc.
- Vielight Inc.